A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants
Clinical trial NCT06752174 · COMPLETED
Trial details
- NCT number
- NCT06752174
- Sponsor
- Beijing Minhai Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-04-12
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.